Wednesday 27 May 2009

Methylphenobarbital




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N03AA01

CAS registry number (Chemical Abstracts Service)

0000115-38-8

Chemical Formula

C13-H14-N2-O3

Molecular Weight

246

Therapeutic Category

Antiepileptic agent

Chemical Names

N-Methyl-5-ethyl-5-phenylbarbituric acid (WHO)

2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-1-methyl-5-phenyl- (USAN)

Foreign Names

  • Methylphenobarbitalum (Latin)
  • Methylphenobarbital (German)
  • Méthylphénobarbital (French)
  • Metilfenobarbital (Spanish)

Generic Names

  • Mephobarbital (OS: JAN)
  • Methylphenobarbital (OS: BAN)
  • Méthylphénobarbital (OS: DCF)
  • Metilfenobarbital (OS: DCIT)
  • Enphenemal (IS)
  • Methylphenobarbitone (IS)
  • Mephobarbital (PH: USP 32)
  • Methylphenobarbital (PH: BP 2010, Ph. Eur. 6)
  • Méthylphénobarbital (PH: Ph. Eur. 6)
  • Methylphenobarbitalum (PH: Ph. Eur. 6)

Brand Names

  • Dintoinale (Methylphenobarbital and Phenytoin)
    Pharmarecord, Italy


  • Mebaral
    Lundbeck, United States


  • Methylphenobarbital
    Rekah, Israel


  • Metinal (Methylphenobarbital and Phenytoin)
    Bayer, Italy


  • Phemiton
    Pliva, Bosnia & Herzegowina; Pliva, Croatia (Hrvatska); Pliva, Slovenia

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday 24 May 2009

Derma-Pax Lotion


Pronunciation: DYE-fen-HYE-dra-meen
Generic Name: Diphenhydramine
Brand Name: Derma-Pax


Derma-Pax Lotion is used for:

Temporarily relieving pain and itching associated with insect bites, minor burns, sunburn, minor skin irritations, minor cuts, scrapes, and rashes due to poison ivy, poison oak, and poison sumac.


Derma-Pax Lotion is an antihistamine. It works by blocking the action of histamine, which reduces the symptoms of an allergic reaction.


Do NOT use Derma-Pax Lotion if:


  • you are allergic to any ingredient in Derma-Pax Lotion

  • you use any other medicine that contains diphenhydramine, unless your doctor tells you to

Contact your doctor or health care provider right away if any of these apply to you.



Before using Derma-Pax Lotion:


Some medical conditions may interact with Derma-Pax Lotion. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have the blood disease porphyria

Some MEDICINES MAY INTERACT with Derma-Pax Lotion. Because little, if any, of Derma-Pax Lotion is absorbed into the blood, the risk of it interacting with another medicine is low.


Ask your health care provider if Derma-Pax Lotion may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Derma-Pax Lotion:


Use Derma-Pax Lotion as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Wash and completely dry the affected area. Gently rub the medicine in until it is evenly distributed. Apply to the affected area not more than 3 to 4 times a day.

  • Wash your hands immediately after using Derma-Pax Lotion.

  • If you miss a dose of Derma-Pax Lotion and you are using it regularly, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule.

Ask your health care provider any questions you may have about how to use Derma-Pax Lotion.



Important safety information:


  • Derma-Pax Lotion may cause harm if it is swallowed. If you may have taken it by mouth, contact your poison control center or emergency room right away.

  • Derma-Pax Lotion is for external use only. Do not get it in your eyes, nose, or mouth. If you get it in your eyes, rinse at once with cool water.

  • If your symptoms do not get better within 7 days or if they get worse, stop using Derma-Pax Lotion and check with your doctor.

  • Do not use Derma-Pax Lotion on chicken pox, measles, or blisters over large areas of your skin unless advised to do so by your doctor.

  • Derma-Pax Lotion contains diphenhydramine. Before you start any new medicine, including one used on the skin, check the label to see if it has diphenhydramine in it too. If it does or if you are not sure, check with your doctor or pharmacist.

  • Derma-Pax Lotion should not be used in CHILDREN younger than 2 years old; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Derma-Pax Lotion while you are pregnant. Derma-Pax Lotion is found in breast milk. If you are or will be breast-feeding while you use Derma-Pax Lotion, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Derma-Pax Lotion:


All medicines may cause side effects, but many people have no, or minor side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Skin irritation.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Derma-Pax side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Derma-Pax Lotion may be harmful if swallowed. Symptoms after swallowing Derma-Pax Lotion may include confusion, hallucinations, or loss of consciousness.


Proper storage of Derma-Pax Lotion:

Store Derma-Pax Lotion at room temperature, between 59 and 77 degrees F (15 and 25 degrees C). Store away from heat, moisture, and light. Keep Derma-Pax Lotion out of the reach of children and away from pets.


General information:


  • If you have any questions about Derma-Pax Lotion, please talk with your doctor, pharmacist, or other health care provider.

  • Derma-Pax Lotion is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Derma-Pax Lotion. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Derma-Pax resources


  • Derma-Pax Side Effects (in more detail)
  • Derma-Pax Use in Pregnancy & Breastfeeding
  • Derma-Pax Drug Interactions
  • Derma-Pax Support Group
  • 0 Reviews for Derma-Pax - Add your own review/rating


Compare Derma-Pax with other medications


  • Pain
  • Pruritus

Saturday 23 May 2009

Levodopa Carbidopa Sandoz




Levodopa Carbidopa Sandoz may be available in the countries listed below.


Ingredient matches for Levodopa Carbidopa Sandoz



Carbidopa

Carbidopa is reported as an ingredient of Levodopa Carbidopa Sandoz in the following countries:


  • Netherlands

Carbidopa monohydrate (a derivative of Carbidopa) is reported as an ingredient of Levodopa Carbidopa Sandoz in the following countries:


  • Germany

Levodopa

Levodopa is reported as an ingredient of Levodopa Carbidopa Sandoz in the following countries:


  • Germany

  • Netherlands

International Drug Name Search

Sunday 17 May 2009

Betamethason Ratiopharm




Betamethason Ratiopharm may be available in the countries listed below.


Ingredient matches for Betamethason Ratiopharm



Betamethasone

Betamethasone 17α-valerate (a derivative of Betamethasone) is reported as an ingredient of Betamethason Ratiopharm in the following countries:


  • Netherlands

International Drug Name Search

Paracetamol dura




Paracetamol dura may be available in the countries listed below.


Ingredient matches for Paracetamol dura



Paracetamol

Paracetamol is reported as an ingredient of Paracetamol dura in the following countries:


  • Germany

International Drug Name Search

Thursday 14 May 2009

Ganirelix




In the US, Ganirelix (ganirelix systemic) is a member of the drug class gonadotropin-releasing hormone antagonists and is used to treat Gonadotropin Inhibition.

US matches:

  • Ganirelix

  • Ganirelix Acetate

  • Ganirelix Subcutaneous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

H01CC01

CAS registry number (Chemical Abstracts Service)

0124904-93-4

Chemical Formula

C80-H113-Cl-N18-O13

Molecular Weight

1570

Therapeutic Category

Gonadotropin releasing hormone (GnRH)-I-receptor antagonist

Chemical Names

D-Alaninamide, N-acetyl-3-(1-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3- -pyridinyl)-D-alanyl-L-seryl-L-tyrosyl-N6-(bis(ethylamino)methyle- ne)-D-lysyl-L-leucyl-N6-(bis(ethylamino)methylene)-L-lysyl-L-prol- yl-

N-Acetyl-3-(2-naphthyl)-D-alanyl-p-chlor-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-seryl-tyrosyl-N'-(N,N'-diethylamidino)-D-lysyl-leucyl-N'-(N,N'-diethylamidino)lysyl-prolyl-D-alaninamid (IUPAC)

N-Acetyl-3-(2-naphthyl)-D-alanyl-p-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-L-tyrosyl-N6-(N,N'-diethylamidino)-D-lysyl-L-leucyl-N6-(N,N'-diethylamidino)-L-lysyl-L-prolyl-D-alaninamide (WHO)

Foreign Names

  • Ganirelixum (Latin)
  • Ganirelix (German)
  • Ganirélix (French)
  • Ganirelix (Spanish)

Generic Names

  • Ganirelix (OS: BAN)
  • Ganirélix (OS: DCF)
  • Ganirelix Acetate (OS: BANM, USAN)
  • Org 37462 (IS: Organon)
  • RS 26306 (IS: Syntax)

Brand Names

  • Orgalutran
    Essex, Germany; Essex Chemie, Switzerland; Organon, United Arab Emirates; Organon, Argentina; Organon, Belgium; Organon, Bahrain; Organon, Chile; Organon, Cyprus; Organon, Czech Republic; Organon, Denmark; Organon, Egypt; Organon, Spain; Organon, Finland; Organon, Greece; Organon, Hong Kong; Organon, Israel; Organon, Iraq; Organon, Iran; Organon, Iceland; Organon, Italy; Organon, Jordan; Organon, Kuwait; Organon, Lebanon; Organon, Luxembourg; Organon, Libya; Organon, Mexico; Organon, Netherlands; Organon, Norway; Organon, Oman; Organon, Portugal; Organon, Qatar; Organon, Romania; Organon, Serbia; Organon, Saudi Arabia; Organon, Sudan; Organon, Singapore; Organon, Slovakia; Organon, Syria; Organon, Thailand; Organon, Turkey; Organon, Taiwan; Organon, Venezuela; Organon, Yemen; Organon N.V., Austria; Schering-Plough, France; Schering-Plough, United Kingdom; Schering-Plough, Sweden


  • Ganirelix Acetate
    Organon, United States


  • Orgalutran
    Organon, Australia; Organon, Brazil; Organon, Canada; Organon, Hungary; Organon, Iceland; Organon, Philippines

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday 9 May 2009

Budelin




Budelin may be available in the countries listed below.


UK matches:

  • Budelin Novolizer 200 mcg

Ingredient matches for Budelin



Budesonide

Budesonide is reported as an ingredient of Budelin in the following countries:


  • United Kingdom

International Drug Name Search

Ramicard plus




Ramicard plus may be available in the countries listed below.


Ingredient matches for Ramicard plus



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Ramicard plus in the following countries:


  • Germany

Ramipril

Ramipril is reported as an ingredient of Ramicard plus in the following countries:


  • Germany

International Drug Name Search